AstraZeneca receives approval for Xigduo XR tablets in India
AstraZeneca Pharma has received marketing authorisation from the Drug Controller General India DCG(I) for Xigduo XR tablets used in treatment of adults with type II […]
Astra Zeneca
Astrazeneca Pharma shuts down Bangalore unit
AstraZeneca Pharma India (AZPIL) the subsidiary of British-Swedish multinational pharmaceutical and biologics company AstraZeneca, has shut down its Active Pharmaceutical Ingredient (API) unit in Bengaluru. […]